Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Lariam
2. Mefloquine
3. Mefloquine Hydrochloride
4. Mephloquine
5. Ro 21 5998 001
6. Ro-21-5998-001
7. Ro215998001
8. Wr 142,490
9. Wr 177,602
10. Wr-142,490
11. Wr-177,602
12. Wr142,490
13. Wr177,602
1. Mefloquine Hydrochloride
2. Mefloquine Hcl
3. 51773-92-3
4. Mefloquine (hydrochloride)
5. Loriam
6. Mefloquine Hydrochloride, (+)
7. 51742-86-0
8. 326vc85gv6
9. Ro 21-5998/001
10. Mefloquinehydrochloride
11. 5y9l3636o3
12. Ro-21-5998/001
13. (s)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2r)-piperidin-2-yl]methanol;hydrochloride
14. Dsstox_cid_27796
15. Dsstox_rid_82568
16. Dsstox_gsid_47819
17. Mls001332559
18. Nsc-157387
19. (r)-[2,8-bis(trifluoromethyl)quinolin-4-yl](2s)-piperidin-2-ylmethanol Hydrochloride
20. (s)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2r)-piperidin-2-yl]methanol Hydrochloride
21. Wr 142490 Hydrochloride
22. Nsc 157387
23. Cas-51773-92-3
24. Mefloquine Hydrochloride [usan]
25. Mefloquin Hydrochloride
26. Ncgc00161831-02
27. Smr000875233
28. Einecs 257-412-0
29. Wr-142490
30. Tcmdc-124288
31. Unii-326vc85gv6
32. Unii-5y9l3636o3
33. Gnf-pf-5559
34. Lariam (tn)
35. Mefloquine Hydrochloride [usan:usp]
36. Ro-215998001
37. Chembl1606
38. Dl-erythro-alpha-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
39. Schembl41094
40. Mls001332560
41. Chebi:6719
42. (+/-)-mefloquine Hcl
43. Dtxsid1047819
44. Tox21_111999
45. Hy-17437a
46. Mfcd00797519
47. S4420
48. Mefloquine Hydrochloride (jp17/usp)
49. Mefloquine Hydrochloride [jan]
50. Akos015919767
51. Tox21_111999_1
52. Ac-4686
53. Ccg-268825
54. Cs-1430
55. Gs-3621
56. Nc00622
57. (r*,s*)-(1)-alpha-2-piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol Monohydrochloride
58. Mefloquine Hydrochloride [mart.]
59. Mefloquine Hydrochloride [vandf]
60. Mefloquine Hydrochloride [usp-rs]
61. Mefloquine Hydrochloride [who-dd]
62. Mefloquine Hydrochloride [who-ip]
63. Ncgc00161831-04
64. 4-quinolinemethanol, Alpha-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (alphas)-rel-
65. 4-quinolinemethanol, Alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (r*,s*)-(+-)-
66. M2313
67. Sw220098-1
68. Mefloquine Hydrochloride [ep Impurity]
69. Mefloquine Hydrochloride [orange Book]
70. D00831
71. Mefloquine Hydrochloride [ep Monograph]
72. Mefloquine Hydrochloride [usp Monograph]
73. Mefloquini Hydrochloridum [who-ip Latin]
74. Mefloquine Hydrochloride, >=98% (hplc), Powder
75. Q-201345
76. Mefloquine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
77. (?s)-rel-?-(2r)-2-piperidinyl-2,3-bis(trifluoromethyl-4-quinolinemethanol Hydrochloride
78. (2,8-bis-trifluoromethylquinolin-4-yl)-piperidin-2-yl-methanol Hydrochloride(r*,s*)
79. Mefloquine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
80. Mefloquine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
81. Rel-(s)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((r)-piperidin-2-yl)methanol Hydrochloride
82. (as)?-?rel-?a-?(2r)?-?2-?piperidinyl-?2,8-?bis(trifluoromethyl)?-?4-?quinolinemethanol Monohydrochloride
83. 4-quinolinemethanol, .alpha,-[(2r)-2-piperidinyl]-2,8-bis(trifluoromethyl)-, (.alpha.s)-, Hydrochloride (1:1)
84. 4-quinolinemethanol, .alpha.-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Hydrochloride (1:1), (.alpha.s)-
85. 4-quinolinemethanol, .alpha.-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (.alpha.s)-
86. 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (r*,s*)- (+/-)-
87. 4-quinolinemethanol, A-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride, (as)-rel-
88. Dl-erythro-.alpha.-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
Molecular Weight | 414.8 g/mol |
---|---|
Molecular Formula | C17H17ClF6N2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 414.0933598 g/mol |
Monoisotopic Mass | 414.0933598 g/mol |
Topological Polar Surface Area | 45.2 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 483 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Mefloquine hydrochloride |
Drug Label | Mefloquine hydrochloride is an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228.0 mg of the free base) for oral administration.Mefloquine hydrochloride is a 4-quinolinemethanol derivative with the specific... |
Active Ingredient | Mefloquine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Sandoz; Roxane; Barr |
2 of 2 | |
---|---|
Drug Name | Mefloquine hydrochloride |
Drug Label | Mefloquine hydrochloride is an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228.0 mg of the free base) for oral administration.Mefloquine hydrochloride is a 4-quinolinemethanol derivative with the specific... |
Active Ingredient | Mefloquine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Sandoz; Roxane; Barr |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A (+/-)-Mefloquine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (+/-)-Mefloquine Hydrochloride, including repackagers and relabelers. The FDA regulates (+/-)-Mefloquine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (+/-)-Mefloquine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (+/-)-Mefloquine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (+/-)-Mefloquine Hydrochloride supplier is an individual or a company that provides (+/-)-Mefloquine Hydrochloride active pharmaceutical ingredient (API) or (+/-)-Mefloquine Hydrochloride finished formulations upon request. The (+/-)-Mefloquine Hydrochloride suppliers may include (+/-)-Mefloquine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of (+/-)-Mefloquine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (+/-)-Mefloquine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of (+/-)-Mefloquine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of (+/-)-Mefloquine Hydrochloride DMFs exist exist since differing nations have different regulations, such as (+/-)-Mefloquine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (+/-)-Mefloquine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. (+/-)-Mefloquine Hydrochloride USDMF includes data on (+/-)-Mefloquine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (+/-)-Mefloquine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (+/-)-Mefloquine Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a (+/-)-Mefloquine Hydrochloride Drug Master File in Korea ((+/-)-Mefloquine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of (+/-)-Mefloquine Hydrochloride. The MFDS reviews the (+/-)-Mefloquine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the (+/-)-Mefloquine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a (+/-)-Mefloquine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their (+/-)-Mefloquine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of (+/-)-Mefloquine Hydrochloride suppliers with KDMF on PharmaCompass.
A (+/-)-Mefloquine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a (+/-)-Mefloquine Hydrochloride Certificate of Suitability (COS). The purpose of a (+/-)-Mefloquine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (+/-)-Mefloquine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (+/-)-Mefloquine Hydrochloride to their clients by showing that a (+/-)-Mefloquine Hydrochloride CEP has been issued for it. The manufacturer submits a (+/-)-Mefloquine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a (+/-)-Mefloquine Hydrochloride CEP holder for the record. Additionally, the data presented in the (+/-)-Mefloquine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (+/-)-Mefloquine Hydrochloride DMF.
A (+/-)-Mefloquine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (+/-)-Mefloquine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (+/-)-Mefloquine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A (+/-)-Mefloquine Hydrochloride written confirmation ((+/-)-Mefloquine Hydrochloride WC) is an official document issued by a regulatory agency to a (+/-)-Mefloquine Hydrochloride manufacturer, verifying that the manufacturing facility of a (+/-)-Mefloquine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting (+/-)-Mefloquine Hydrochloride APIs or (+/-)-Mefloquine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a (+/-)-Mefloquine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of (+/-)-Mefloquine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (+/-)-Mefloquine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (+/-)-Mefloquine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (+/-)-Mefloquine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (+/-)-Mefloquine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (+/-)-Mefloquine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (+/-)-Mefloquine Hydrochloride suppliers with NDC on PharmaCompass.
(+/-)-Mefloquine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (+/-)-Mefloquine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (+/-)-Mefloquine Hydrochloride GMP manufacturer or (+/-)-Mefloquine Hydrochloride GMP API supplier for your needs.
A (+/-)-Mefloquine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to (+/-)-Mefloquine Hydrochloride's compliance with (+/-)-Mefloquine Hydrochloride specifications and serves as a tool for batch-level quality control.
(+/-)-Mefloquine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each (+/-)-Mefloquine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(+/-)-Mefloquine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia ((+/-)-Mefloquine Hydrochloride EP), (+/-)-Mefloquine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((+/-)-Mefloquine Hydrochloride USP).
LOOKING FOR A SUPPLIER?